Argilés, G., Mulet, N., Valladares Ayerbes, M., Viéitez, J. M., Grávalos, C., García Alfonso, P., . . . investigators, T. R. (2022). A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Citación estilo ChicagoArgilés, Guillem, et al. A Randomised Phase 2 Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in Previously Treated Metastatic Colorectal Cancer Patients (REARRANGE Trial). 2022.
Cita MLAArgilés, Guillem, et al. A Randomised Phase 2 Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in Previously Treated Metastatic Colorectal Cancer Patients (REARRANGE Trial). 2022.